{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T03:56:35Z","timestamp":1772596595679,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1007\/s11894-996-0006-8","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T15:51:07Z","timestamp":1180799467000},"page":"95-101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Biliary tract inflammatory disorders: Primary sclerosing cholangitis and primary biliary cirrhosis"],"prefix":"10.1007","volume":"1","author":[{"given":"Jos\u00e9","family":"Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kia","family":"Saeian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,4,1]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/gut.24.1.38","volume":"24","author":"RW Chapman","year":"1983","unstructured":"Chapman RW, Varghese Z, Gaul R, et al.: Association of primary sclerosing cholangitis with HLA-B8. Gut 1983, 24:38\u201341.","journal-title":"Gut"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/00365528209182038","volume":"17","author":"E Schrumpf","year":"1982","unstructured":"Schrumpf E, Fausa O, Fore O, et al.: HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 1982, 17:187\u2013191.","journal-title":"Scand J Gastroenterol"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/hep.1840130119","volume":"13","author":"PT Donaldson","year":"1991","unstructured":"Donaldson PT, Farrant JM, Wilkinson ML, et al.: Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 1991, 13:129\u2013133.","journal-title":"Hepatology"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00042737-199611000-00012","volume":"8","author":"R Seibold","year":"1996","unstructured":"Seibold R, Weber P, Schoning A, et al.: Neutrophil antibodies (pANCA) in chronic liver disease: do they react with different antigens?\nEur J Gastroenterol Hepatol 1996, 8:1095\u20131100.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2008-1040541","volume":"8","author":"E Schrumpf","year":"1988","unstructured":"Schrumpf E, Fausa O, Elgio K, et al.: Hepatobiliary complications of inflammatory bowel disease. Semin Liver Dis 1988, 8:201\u2013209.","journal-title":"Semin Liver Dis"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/hep.1840100406","volume":"10","author":"RH Wiesner","year":"1989","unstructured":"Wiesner RH, Grambsch PM, Dickson ER, et al.: Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989, 10:430\u2013436.","journal-title":"Hepatology"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/hep.1840010612","volume":"1","author":"J Ludwig","year":"1981","unstructured":"Ludwig J, Barham SS, LaRusso NF, et al.: Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1981, 1:632\u2013640.","journal-title":"Hepatology"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0046-8177(82)80011-7","volume":"13","author":"MJ Finegold","year":"1982","unstructured":"Finegold MJ, Carpenter RJ: Obliterative cholangitis due to cytomegalovirus: a possible precursor of paucity of intrahepatic bile ducts. Hum Pathol 1982, 13:662\u2013665.","journal-title":"Hum Pathol"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1136\/gut.21.5.428","volume":"21","author":"RT Holzbach","year":"1980","unstructured":"Holzbach RT, Marsh ME, Freedman MR, et al.: Portal vein bile acids in patients with severe inflammatory bowel disease. Gut 1980, 21:428\u2013435.","journal-title":"Gut"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0016-5085(19)30491-3","volume":"78","author":"MJ Dew","year":"1980","unstructured":"Dew MJ, van Berge Henegouwen GP, Huybregts AW, et al.: Hepatotoxic effect of bile acids in inflammatory bowel disease. Gastroenterology 1980, 78:1393\u20131401.","journal-title":"Gastroenterology"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/0016-5085(85)90326-9","volume":"89","author":"JB Gross Jr","year":"1985","unstructured":"Gross JB Jr, Ludwig J, Wiesner RH, et al.: Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. Gastroenterology 1985, 89:272\u2013278.","journal-title":"Gastroenterology"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1089-3261(05)70008-8","volume":"2","author":"A Bergquist","year":"1998","unstructured":"Bergquist A, Broom\u00e9 U: Clinical features in primary sclerosing cholangitis. Clin Liver Dis 1998, 2:283\u2013301.","journal-title":"Clin Liver Dis"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2214\/ajr.150.3.571","volume":"150","author":"DJ Brandt","year":"1988","unstructured":"Brandt DJ, MacCarty RL, Charboneau JW, et al.: Gallbladder disease in patients with primary sclerosing cholangitis. Am J Roentgenol 1988, 150:571\u2013574.","journal-title":"Am J Roentgenol"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3109\/00365528709011139","volume":"22","author":"E Aadland","year":"1997","unstructured":"Aadland E, Schrumpf E, Fausa O, et al.: Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1997, 22:655\u2013664.","journal-title":"Scand J Gastroenterol"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","volume":"100","author":"JM Farrant","year":"1991","unstructured":"Farrant JM, Hayllar KM, Wilkinson ML, et al.: Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991, 100:1710\u20131717.","journal-title":"Gastroenterology"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-2008-1040419","volume":"11","author":"CB Rosen","year":"1991","unstructured":"Rosen CB, Nagorney DM: Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 1991, 11:26\u201330.","journal-title":"Semin Liver Dis"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1136\/gut.38.4.610","volume":"38","author":"U Broom\u00e9","year":"1996","unstructured":"Broom\u00e9 U, Olsson R, Loof L, et al.: Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996, 38:610\u2013615. In this study, 305 patients with PSC were followed for a median of 63 months. Multivariate analyses were used to evaluate key end points, including liver transplantation, development of cholangiocarcinoma, and death.","journal-title":"Gut"},{"key":"6_CR18","first-page":"1022","volume":"91","author":"KL Carson","year":"1996","unstructured":"Carson KL, Tran TT, Cotton P, et al.: Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease. Am J Gastroenterol 1996, 91:1022\u20131023.","journal-title":"Am J Gastroenterol"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"1858A","DOI":"10.1016\/S0016-5107(97)80395-1","volume":"45","author":"A Bohorfoush","year":"1997","unstructured":"Bohorfoush A, Franco J, Komorowski R, et al.: Flow cytometric analysis of bile duct epithelium in primary sclerosing cholangitis potentially assists timing of liver transplantation. Gastrointest Endosc 1997, 45:1858A.","journal-title":"Gastrointest Endosc"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1056\/NEJM199703063361003","volume":"336","author":"KD Lindor","year":"1997","unstructured":"Lindor KD, for the Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group: Urosodiol for primary sclerosing cholangitis. N Engl J Med 1997, 336:691\u2013695. This randomized double-blind study evaluated the effectiveness of UDCA in the treatment of PSC. End points addressed included biochemical, histologic, and clinical deterioration; the need for liver transplantation; and death.","journal-title":"N Engl J Med"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0168-8278(05)80467-2","volume":"20","author":"A Stiehl","year":"1994","unstructured":"Stiehl A, Walker S, Stiehl L, et al.: Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis: a 30 year pilot study with a placebo-controlled study period. J Hepatol 1994, 20:57\u201364.","journal-title":"J Hepatol"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/0016-5085(95)90220-1","volume":"108","author":"R Olsson","year":"1995","unstructured":"Olsson R, Broom\u00e9 U, Danielsson A, et al.: Colchicine treatment of primary sclerosing cholangitis. Gastroenterology 1995, 108:1199\u20131203.","journal-title":"Gastroenterology"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/0016-5085(88)90180-1","volume":"95","author":"NF LaRusso","year":"1988","unstructured":"LaRusso NF, Wiesner RH, Ludwig J, et al.: Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 1988, 95:1036\u20131042.","journal-title":"Gastroenterology"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/0016-5085(94)90610-6","volume":"106","author":"TA Knox","year":"1994","unstructured":"Knox TA, Kaplan MM: A double-blind controlled trial of oralpulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994, 106:494\u2013499.","journal-title":"Gastroenterology"},{"key":"6_CR25","first-page":"57","volume":"85","author":"KD Lindor","year":"1991","unstructured":"Lindor KD, Wiesner RH, Colwell LJ: The combination of prednisone and colchicine in patients with primary sclerosing cholangitis. Am J Gastroenterol 1991, 85:57\u201361.","journal-title":"Am J Gastroenterol"},{"key":"6_CR26","first-page":"449","volume":"41","author":"K Kyokane","year":"1994","unstructured":"Kyokane K, Ichihara T, Horisawa M, et al.: Successful treatment of primary sclerosing cholangitis with cyclosporine and corticosteroid. Hepatogastroenterology 1994, 41:449\u2013452.","journal-title":"Hepatogastroenterology"},{"key":"6_CR27","first-page":"455","volume":"90","author":"DH Van Thiel","year":"1995","unstructured":"Van Thiel DH, Carroll P, Abu-Elmagd K, et al.: Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol 1995, 90:455\u2013459.","journal-title":"Am J Gastroenterol"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/hep.1840100406","volume":"10","author":"RH Wiesner","year":"1989","unstructured":"Wiesner RH, Brambsch PM, Dickson ER, et al.: Primary sclerosing cholangitis: natural history, prognostic factors, and survival analysis. Hepatology 1989, 10:430\u2013436.","journal-title":"Hepatology"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/0016-5085(92)91449-E","volume":"103","author":"ER Dickson","year":"1992","unstructured":"Dickson ER, Murtaugh PA, Wiesner RH, et al.: Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 1992, 103:1893\u20131901.","journal-title":"Gastroenterology"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","volume":"100","author":"JM Farrant","year":"1991","unstructured":"Farrant JM, Hayllar KM, Wilkinson ML, et al.: Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991, 100:1710\u20131717.","journal-title":"Gastroenterology"},{"issue":"suppl 5","key":"6_CR31","first-page":"109","volume":"1","author":"J Neuberger","year":"1995","unstructured":"Neuberger J: Recurrence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis. Liver Transplant Surg 1995, 1(suppl 5):109\u2013115.","journal-title":"Liver Transplant Surg"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/bmj.312.7040.1181","volume":"312","author":"J Metcalf","year":"1996","unstructured":"Metcalf J, Howel D, James O, et al.: Primary biliary cirrhosis: epidemiology helping the clinician. BMJ 1996, 312:1181\u20131182.","journal-title":"BMJ"},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/hep.1840120116","volume":"12","author":"H Witt-Sullivan","year":"1990","unstructured":"Witt-Sullivan H, Heathcote EJ, Cauch K, et al.: The demography of primary biliary cirrhosis in Ontario, Canada. Hepatology 1990, 12:98\u2013105.","journal-title":"Hepatology"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0168-8278(05)80137-0","volume":"20","author":"N Bach","year":"1994","unstructured":"Bach N, Schaffner F: Familial primary biliary cirrhosis. J Hepatol 1994, 20:698\u2013701.","journal-title":"J Hepatol"},{"key":"6_CR35","first-page":"108A","volume":"22","author":"K Cauch-Dudek","year":"1995","unstructured":"Cauch-Dudek K, Abbey S, Stewart DE, et al.: Fatigue and quality of life in primary biliary cirrhosis. Hepatology 1995, 22:108A.","journal-title":"Hepatology"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/hep.1840150518","volume":"15","author":"JF Crippin","year":"1992","unstructured":"Crippin JF, Lindor KD, Jorgensen R, et al.: Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?\nHepatology 1992, 15:858\u2013862.","journal-title":"Hepatology"},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0168-8278(87)80035-1","volume":"5","author":"M Navasa","year":"1987","unstructured":"Navasa M, Pares A, Brugera M, et al.: Portal hypertension in primary biliary cirrhosis: relationship with histological features. J Hepatol 1987, 5:292\u2013298.","journal-title":"J Hepatol"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/0016-5085(84)90540-7","volume":"87","author":"WM Melia","year":"1984","unstructured":"Melia WM, Johnson PJ, Neuberger J, et al.: Hepatocellular carcinoma in primary biliary cirrhosis: detection by alphafetoprotein estimation. Gastroenterology 1984, 87:660\u2013663.","journal-title":"Gastroenterology"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","volume":"138","author":"ME Gershwin","year":"1987","unstructured":"Gershwin ME, Mackay IR, Sturgess A, et al.: Identification and specificity of a cDNA encoding the 70-kDa mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987, 138:3525\u20133531.","journal-title":"J Immunol"},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0140-6736(88)91894-6","volume":"1","author":"SJ Yeaman","year":"1988","unstructured":"Yeaman SJ, Fussey SPM, Danner DJ, et al.: Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1988, 1:1067\u20131070.","journal-title":"Lancet"},{"key":"6_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1055\/s-2007-1007180","volume":"17","author":"EJ Heathcote","year":"1996","unstructured":"Heathcote EJ: The clinical expression of primary biliary cirrhosis. Semin Liver Dis 1996, 17:23\u201333. The author presents a concise review of the clinical presentation of primary biliary cirrhosis and its associated extrahepatic disorders.","journal-title":"Semin Liver Dis"},{"key":"6_CR42","first-page":"1257","volume":"60","author":"PJ Scheuer","year":"1967","unstructured":"Scheuer PJ: Primary biliary cirrhosis. Proc R Soc Med 1967, 60:1257\u20131260.","journal-title":"Proc R Soc Med"},{"key":"6_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00432479","volume":"379","author":"J Ludwig","year":"1978","unstructured":"Ludwig J, Dickson ER, McDonald GSA: Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch 1978, 379:103\u2013112.","journal-title":"Virchows Arch"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/gut.20.2.137","volume":"20","author":"J Shapiro","year":"1979","unstructured":"Shapiro J, Smith H, Schaffner F: Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979, 20:137\u2013140.","journal-title":"Gut"},{"key":"6_CR45","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1136\/gut.31.9.1069","volume":"31","author":"JM Neuberger","year":"1990","unstructured":"Neuberger JM, Gunson BK, Buckels JAC, et al.: Referral of patients with primary biliary cirrhosis for liver transplantation. Gut 1990, 31:1069\u20131072.","journal-title":"Gut"},{"key":"6_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hep.1840100102","volume":"10","author":"ER Dickson","year":"1989","unstructured":"Dickson ER, Grambsch PM, Fleming TR, et al.: Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989, 10:1\u20137.","journal-title":"Hepatology"},{"key":"6_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/00365529009107932","volume":"25","author":"A Rydning","year":"1990","unstructured":"Rydning A, Schrumpf E, Abdelnoor M, et al.: Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 1990, 25:119\u2013126.","journal-title":"Scand J Gastroenterol"},{"key":"6_CR48","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/0016-5085(93)91086-W","volume":"105","author":"E Christensen","year":"1993","unstructured":"Christensen E, Altman DG, Neuberger J, et al.: Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. Gastroenterology 1993, 105:1865\u20131876.","journal-title":"Gastroenterology"},{"key":"6_CR49","first-page":"1148","volume":"23","author":"MR Kilmurry","year":"1996","unstructured":"Kilmurry MR, Heathcote EJ, Cauch-Dudek K, et al.: Is the Mayo model for predicting survival useful after introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?\nHepatology 1996, 23:1148\u20131153.","journal-title":"Hepatology"},{"key":"6_CR50","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","volume":"113","author":"RE Poupon","year":"1997","unstructured":"Poupon RE, Lindor KD, Cauch-Dudek K, et al.: Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997, 113:884\u2013890. This analysis of the combined data of three large trials of UDCA therapy in patients with PBC demonstrates that long-term UDCA improves survival without liver transplantation in patients with moderate or severe disease.","journal-title":"Gastroenterology"},{"key":"6_CR51","first-page":"248A","volume":"26","author":"M Hendrickse","year":"1997","unstructured":"Hendrickse M, Rigney E, Giaffer MH, et al.: Low-dose methotrexate in primary biliary cirrhosis: long-term results of a placebo-controlled trial. Hepatology 1997, 26:248A.","journal-title":"Hepatology"},{"key":"6_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0168-8278(05)80244-2","volume":"18","author":"SG Hubscher","year":"1993","unstructured":"Hubscher SG, Elias E, Buckels JAC, et al.: Primary biliary cirrhosis: histological evidence of disease recurrence after liver transplantation. J Hepatol 1993, 18:173\u2013184.","journal-title":"J Hepatol"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-996-0006-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-996-0006-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-996-0006-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-996-0006-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T03:02:53Z","timestamp":1772593373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-996-0006-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s11894-996-0006-8","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4]]},"assertion":[{"value":"1 April 1999","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}